CLAJ_image
DBASSE_bottom_image
Wednesday, November 26, 2014 
Top Image Display(is skipping to image description)

   CLAJ - TOPICS

Adjudication: Courts and Sentencing

Corrections: Incarceration and Supervision

Crime: Causes, Trends, and Prevention

Delinquency: Prevention, Intervention, and Justice

Domestic and Personal Security: Terrorism and Cyber Security

Evaluation: Programs and Policies

Investigation and Enforcement: Policing, Forensics, and Regulations

Research: Data and Measurement

Victims: Vulnerable Populations and Family Violence

Committee on Data and Research for Policy on Illegal Drugs 

 

Project Scope

The committee will review statistical, scientific, and clinical research, policy studies, program evaluations, and other assessments of drug control initiatives, projects and systems, and provide new understanding from a re-analysis of selected research data sets on drug abuse and drug trafficking. This synthesis of published knowledge will be augmented by expert opinion through workshops and commissioned papers. The committee will also integrate research knowledge on drug abuse and drug markets with emerging cultural factors that contribute to the ways in which drug abuse becomes embedded in the context of community life. Through these mechanisms, the committee will recommend new insights that will advance theory, support decision making, and lead to the development of new strategies in the area of drug control.

 

Sponsor
White House Office of National Drug Control Policy

 

Committee Membership
CHARLES F.MANSKI (Chair), Department of Economics and Institute for Policy Research, Northwestern University
JAMES C.ANTHONY, School of Hygiene and Public Health, Johns Hopkins University
ALFRED BLUMSTEIN, H.John Heinz III School of Public Policy and Management, Carnegie Mellon University
RICHARD J.BONNIE, School of Law, University of Virginia
JEANETTE COVINGTON, Department of Sociology, Rutgers, The State University of New Jersey
DENISE C.GOTTFREDSON, Department of Criminology and Criminal Justice, University of Maryland
PHILIP B.HEYMANN, Center for Criminal Justice, Harvard Law School
JOEL L.HOROWITZ, Department of Economics, The University of Iowa
ROBERT J.MACCOUN, School of Law and Richard and Rhoda Goldman School of Public Policy, University of California, Berkeley
MARK H.MOORE, Kennedy School of Government, Harvard University
WILLIAM NORDHAUS, Department of Economics, Yale University
CHARLES O’BRIEN, VA Medical Center, University of Pennsylvania
ROBERT H.PORTER, Department of Economics, Northwestern University
PAUL R.ROSENBAUM, Department of Statistics, University of Pennsylvania
JAMES Q.WILSON, Anderson Graduate School of Management, University of California, Los Angeles
DARNELL F.HAWKINS (Liaison, Committee on Law and Justice), Department of African American Studies, University of Illinois at Chicago
 

Staff
CAROL V.PETRIE, Study Director
JOHN V.PEPPER (Consultant), Department of Economics, University of Virginia
KATHLEEN FRYDL, Research Associate
RALPH PATTERSON, Senior Project Assistant 

 
Informing America's Policy on Illegal Drugs: What We Don't Know Keeps Hurting Us (2001)
   

 Informing Americas Policy of Illegal Drugs report cover

 Report

 

 

How should the war on drugs be fought? Everyone seems to agree that the United States ought to use a combination of several different approaches to combat the destructive effects of illegal drug use. Yet there is a remarkable paucity of data and research information that policy makers require if they are to create a useful, realistic policy package-details about drug use, drug market economics, and perhaps most importantly the impact of drug enforcement activities.   

 

Informing America's Policy on Illegal Drugs recommends ways to close these gaps in our understanding-by obtaining the necessary data on drug prices and consumption (quantity in addition to frequency); upgrading federal management of drug statistics; and improving our evaluation of prevention, interdiction, enforcement, and treatment efforts. 

 

The committee reviews what we do and do not know about illegal drugs and how data are assembled and used by federal agencies. The book explores the data and research information needed to support strong drug policy analysis, describes the best methods to use, explains how to avoid misleading conclusions, and outlines strategies for increasing access to data. Informing America's Policy on Illegal Drugs also discusses how researchers can incorporate randomization into studies of drug treatment and how state and local agencies can compare alternative approaches to drug enforcement.

 

Charting a course toward a better-informed illegal drugs policy, this book will be important to federal and state policy makers, regulators, researchers, program administrators, enforcement officials, journalists, and advocates concerned about illegal drug use. 

   
   

 

The National Academies